Huiying Fu

1.2k total citations
61 papers, 891 citations indexed

About

Huiying Fu is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Huiying Fu has authored 61 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Immunology and 9 papers in Pharmacology. Recurrent topics in Huiying Fu's work include Immune cells in cancer (8 papers), Pharmacological Effects of Natural Compounds (6 papers) and Asthma and respiratory diseases (5 papers). Huiying Fu is often cited by papers focused on Immune cells in cancer (8 papers), Pharmacological Effects of Natural Compounds (6 papers) and Asthma and respiratory diseases (5 papers). Huiying Fu collaborates with scholars based in China, United States and Czechia. Huiying Fu's co-authors include Qiyang Shou, Lu Jin, Xia Liu, Yang Yao, Qiang Gao, Yiqiang Jiang, Yuehai Ke, Fangmei Zhou, Zhishan Ding and Junfeng Yan and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Journal of Materials Science.

In The Last Decade

Huiying Fu

55 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiying Fu China 18 308 127 103 96 84 61 891
Xiangyun Chen China 19 449 1.5× 108 0.9× 52 0.5× 84 0.9× 33 0.4× 63 952
Donghui Liu China 20 346 1.1× 121 1.0× 41 0.4× 57 0.6× 68 0.8× 49 907
Jianhua Li China 16 320 1.0× 70 0.6× 41 0.4× 51 0.5× 53 0.6× 31 873
Xinwei Liu China 18 317 1.0× 58 0.5× 52 0.5× 133 1.4× 51 0.6× 63 853
Yanzhuo Liu China 18 502 1.6× 127 1.0× 83 0.8× 127 1.3× 26 0.3× 41 907
Zhenxiang Yu China 14 306 1.0× 134 1.1× 41 0.4× 71 0.7× 28 0.3× 38 821
Lifeng Jiang China 23 515 1.7× 98 0.8× 39 0.4× 97 1.0× 43 0.5× 57 1.3k
Ruiling Xu China 19 457 1.5× 71 0.6× 34 0.3× 91 0.9× 28 0.3× 61 1.0k
Yifan Wu China 20 447 1.5× 76 0.6× 56 0.5× 74 0.8× 57 0.7× 50 1.1k
Sheng Liu China 18 678 2.2× 80 0.6× 96 0.9× 106 1.1× 97 1.2× 119 1.8k

Countries citing papers authored by Huiying Fu

Since Specialization
Citations

This map shows the geographic impact of Huiying Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiying Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiying Fu more than expected).

Fields of papers citing papers by Huiying Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiying Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiying Fu. The network helps show where Huiying Fu may publish in the future.

Co-authorship network of co-authors of Huiying Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Huiying Fu. A scholar is included among the top collaborators of Huiying Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiying Fu. Huiying Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jin, Lu, Jianhui Fu, Jingan Lou, et al.. (2025). PARP1 Exacerbates Prostatitis by Promoting M1 Macrophages Polarization through NF-κB Pathway. Inflammation. 48(5). 3022–3035. 3 indexed citations
3.
Guo, Yingxue, Min Chen, Yuan Qi, et al.. (2025). Modulating phosphodiesterase-5 activity to suppress the immunosuppressive mechanisms of myeloid-derived suppressor cells in breast cancer. Breast Cancer Research. 27(1). 184–184.
4.
Fu, Huiying, et al.. (2024). FOS‐Mediated PLCB1 Induces Radioresistance and Weakens the Antitumor Effects of CD8+ T Cells in Triple‐Negative Breast Cancer. Molecular Carcinogenesis. 64(1). 162–175. 4 indexed citations
5.
Liu, Xia, et al.. (2023). Tetrastigma polysaccharide reprogramming of tumor-associated macrophages via PPARγ signaling pathway to play antitumor activity in breast cancer. Journal of Ethnopharmacology. 314. 116645–116645. 17 indexed citations
6.
Gong, Lihong, et al.. (2023). Fabricating the multibranch carboxyl-modified cellulose for hemorrhage control. Materials Today Bio. 24(4). 100878–100878. 5 indexed citations
8.
Jin, Lu, Yueqin Cai, Quanxin Ma, et al.. (2021). Hirsutella sinensis fungus improves cardiac function in mouse model of heart failure. Biomedicine & Pharmacotherapy. 142. 111885–111885. 7 indexed citations
9.
10.
Shan, Qiyuan, Juli Wang, Hui Hui, et al.. (2020). Change in the active component of processed Tetradium ruticarpum extracts leads to improvement in efficacy and toxicity attenuation. Journal of Ethnopharmacology. 264. 113292–113292. 15 indexed citations
11.
Fu, Huiying, et al.. (2020). High-Fat Diet Promotes Macrophage-Mediated Hepatic Inflammation and Aggravates Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice. Frontiers in Nutrition. 7. 585306–585306. 27 indexed citations
12.
Zhang, Lizong, Lu Jin, Beibei Cao, et al.. (2020). Effect of Hirsutella sinensis Fungus on the Hypothalamic‐Pituitary‐Adrenal Axis in Lewis Rats with Kidney‐Yang Deficiency Syndrome. Evidence-based Complementary and Alternative Medicine. 2020(1). 5952612–5952612. 10 indexed citations
13.
Yan, Ping, Xia Liu, Lu Jin, et al.. (2020). Crude Radix Aconiti Lateralis Preparata (Fuzi) with Glycyrrhiza Reduces Inflammation and Ventricular Remodeling in Mice through the TLR4/NF-κB Pathway. Mediators of Inflammation. 2020. 1–13. 33 indexed citations
14.
Zhao, Fan, et al.. (2019). Effect of HongJing I in Treating Erectile Function and Regulating RhoA Pathway in a Rat Model of Bilateral Cavernous Nerve Injury. Evidence-based Complementary and Alternative Medicine. 2019. 1–11. 6 indexed citations
15.
Zhao, Fan, et al.. (2017). The Protective Effect of Salidroside on Hypoxia‐Induced Corpus Cavernosum Smooth Muscle Cell Phenotypic Transformation. Evidence-based Complementary and Alternative Medicine. 2017(1). 3530281–3530281. 15 indexed citations
16.
Liu, Xia, Qiyang Shou, Junfeng Yan, et al.. (2016). Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway. Journal of Ethnopharmacology. 193. 538–545. 40 indexed citations
17.
Fu, Huiying. (2012). Comparison and Characterization on Immunomodulatory Function of Hirsutella sinensis and Paecilomyces hepiali in Mice. 2 indexed citations
18.
Sun, Mingjiao, Huiying Fu, Hongqiang Cheng, et al.. (2012). A dynamic real-time method for monitoring epithelial barrier function in vitro. Analytical Biochemistry. 425(2). 96–103. 47 indexed citations
19.
Mou, Xiaozhou, Yifei Li, Shanshan Zhang, et al.. (2011). Phenotypic Pattern-Based Assay for Dynamically Monitoring Host Cellular Responses to Salmonella Infections. PLoS ONE. 6(11). e26544–e26544. 12 indexed citations
20.
Shou, Qiyang, et al.. (2010). Prevention of strain fermentation in Hirsutella sinensis on type 1 diabetes of non-obese diabetic mice.. Zhongcaoyao. 41(8). 1311–1315. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026